期刊文献+

急性髓系白血病中异柠檬酸脱氢酶1基因突变的生物信息学分析

Bioinformatics Analysis for Isocitrate Dehydrogenase 1 Mutation in Acute Myeloid Leukemia
下载PDF
导出
摘要 目的从分子水平揭示合并异柠檬酸脱氢酶1(IDH1)基因突变的正常核型急性髓系白血病(CN-AML)患者的发病机制,为临床诊疗提供新工具。方法在GEO中检索IDH1突变的AML芯片数据,使用BRB-Array Tools、GSEA、MILANO、GAD、GATHER等生物信息学工具进行统合分析。结果经过2组样本数据的统合分析,发现12个差异表达基因,主要集中在细胞粘附、免疫防御反应等生物学过程。与参与凋亡、Toll-like、Jak-Stat等信号通路有关。GSEA分析表明IDH1相关基因分别涉及到脂质代谢、髓系细胞分化和缺氧调节等方面。结论利用生物信息学的方法能提取基因芯片有效信息,为进一步深入研究IDH1在CN-AML的发病机制中的作用开辟新思路。 Objective To understand the molecular pathogenesis of isocitrate dehydrogenase 1(IDH1)mutation in the subgroup of cytogenetically normal acute myeloid leukemia(CN-AML),and provide novel means for clinical diagnosis and treatment of AML.Methods Gene expression profiles were obtained from GEO database,and a set of bioinformatics tools,such as BRB-Array Tools,GSEA,MILANO,GAD,GATHER were used to accomplish the data-mining.Results After combined the results of two independent sample sets,12 differentially expressed genes were identified,which were involved in cell adhesion,immunity,etc.IDH1 related genes played essential roles in such important signal pathway Toll-like,Jak-Stat.GSEA analysis results suggested that IDH1-related genes might mainly affect the biological progress in lipid metabolism,myeloid cell differentiation and hypoxia regulation.Conclusion Bioinformatics analysis can effectively process the gene chip data.The pathogenesis of IDH1 mutation involves abnormal expression of multiple genes,and these data may benefit further investigations of the pathogenesis of CN-AML with IDH1 mutation.
出处 《华中科技大学学报(医学版)》 CAS CSCD 北大核心 2012年第4期404-408,共5页 Acta Medicinae Universitatis Scientiae et Technologiae Huazhong
基金 国家杰出青年科学基金资助项目(No.81025011)
关键词 异柠檬酸脱氢酶1 差异表达 基因芯片 GEO数据库 生物信息学 isocitrate dehydrogenase 1; differential expression; microarray; GEO database; bioinformatics
  • 相关文献

参考文献9

  • 1Dohner H,Estey E H,Amadori S,et al.Diagnosis and management of acute myeloid leukemia in adults:recommendations from an international expert panel,on behalf of the European Leukemia Net[J].Blood,2010,115(3):453-474.
  • 2Vardiman J W,Thiele J,Arber D A,et al.The 2008 revision of the WHO classification of myeloid neoplasms and acute leukemia:rationale and important changes[J].Blood,2009,114(5):937-951.
  • 3Boissel N,Nibourel O,Renneville A,et al.Prognostic impact of isocitrate dehydrogenase enzyme isoforms 1 and 2 mutations in acute myeloid leukemia:a study by the Acute Leukemia French Association group[J].J Clin Oncol,2010,28(23):3717-3723.
  • 4Paschka P,Schlenk R F,Gaidzik V I,et al.IDH1 and IDH2 mutations are frequent genetic alterations in acute myeloid leukemia and confer adverse prognosis in cytogenetically normal acute myeloid leukemia with NPM1 mutation without FLT3 internal tandem duplication[J].J Clin Oncol,2010,28(22):3636-3643.
  • 5De Jonge H J,Valk P J,Veeger N J,et al.High VEGFC expression is associated with unique gene expression profiles and predicts adverse prognosis in pediatric and adult acute myeloid leukemia[J].Blood,2010,116(10):1747-1754.
  • 6Tomasson M H,Xiang Z,Walgren R,et al.Somatic mutations and germline sequence variants in the expressed tyrosine kinase genes of patients with de novo acute myeloid leukemia[J].Blood,2008,111(9):4797-4808.
  • 7Zhao Y,Simon R.BRB-Array Tools Data Archive for human cancer gene expression:a unique and efficient data sharing resource[J].Cancer Inform,2008,6:9-15.
  • 8Zwaan C M,Kaspers G J,Pieters R,et al.Cellular drug resistance profiles in childhood acute myeloid leukemia:differences between FAB types and comparison with acute lymphoblastic leukemia[J].Blood,2000,96(8):2879-2886.
  • 9Spijkers-Hagelstein J A,Schneider P,Hulleman E,et al.Elevated S100 A8/S100 A9 expression causes glucocorticoid resistance in MLL-rearranged infant acute lymphoblastic leukemia[J].Leukemia,2012,26(6):1255-1265.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部